Book Online or Call 1-855-SAUSALITO
Sign In \| Register \| About Sausalito \| Contact Us
Sausalito, CA September 01, 2020 1:41pm 7-Day Forecast \| Traffic

- Apartments

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Wuxi Biologics Unsp/Adr (OP:WXXWY)

10.55 +0.13 (+1.25%)

Streaming Delayed Price Updated: 3:57 PM EST, Feb 13, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	29,468
Open	10.40
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	10.42
Today's Range	10.11 - 10.55
52wk Range	4.140 - 11.21
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Trump Reportedly Warns Big Pharma: Move Manufacturing To US Or Face Tariffs ↗

February 24, 2025

President Donald Trump has issued a stringent warning to pharmaceutical companies, advising them to repatriate their manufacturing to the US or face the possibility of tariffs.

Via Benzinga

Week In Review: Curon Out-Licenses T-Cell-Engager To Merck For $700 Million Upfront ↗

August 10, 2024

Curon Biopharmaceutical, a Shanghai company, out-licensed global rights for a clinical-stage bispecific candidate to Merck (MSD) for $700 million upfront plus $600 million in milestones.

Via Talk Markets

Performance

YTD	+26.3%	+26.3%
1 Month	+3.6%	+3.6%
3 Month	+28.7%	+28.7%
6 Month	+34.2%	+34.2%
1 Year	+74.1%	+74.1%

More News

Week In Review: Three Multinationals Plan Investments In Southeast Asia Facilities ↗

March 23, 2024

Via Talk Markets

Congressional Scrutiny Intensifies On Chinese Biotech Firms: WuXi AppTec Faces Biotech Exodus ↗

March 14, 2024

Via Benzinga

Week In Review: BeiGene Options DualityBio ADC In $1.3 Billion Agreement ↗

July 15, 2023

Via Talk Markets

Week In Review: BeiGene Signs $1.3 Billion Deal For Preclinical CDK2 Inhibitor From Boston’s Ensem ↗

November 25, 2023

Via Talk Markets

Week In Review: Legend Partners DLL3 CAR-T Candidate With Novartis In $1.2 Billion Deal ↗

November 18, 2023

Via Talk Markets

Week In Review: Eccogen Out-Licenses GLP-1 Agonist To AstraZeneca In $2 Billion Deal ↗

November 11, 2023

Via Talk Markets

Strong Consumer Turnout Drives Hong Kong Stocks Higher Friday As China's Former Premier Li Keqiang Dies At 68 ↗

October 27, 2023

Via Benzinga

Week In Review: China's Biopharmas Announce $2.5 Billion In Deals ↗

October 21, 2023

Via Talk Markets

Week In Review: QYuns Plans Hong Kong IPO For Autoimmune/Allergic Disease Portfolio ↗

October 07, 2023

Via Talk Markets

Week In Review: WuXi Biologics Out-Licenses Four TCE Antibodies To GSK In $1.5 Billion Pact ↗

January 07, 2023

Via Talk Markets

Week In Review: Ten Biggest 2022 China Biopharma Deals Worth $21.5 Billion ↗

December 31, 2022

Via Talk Markets

Wuxi Biologics Will Be Removed From U.S. Commerce Department's ‘Unverified List’ ↗

October 09, 2022

Via Talk Markets

Frequently Asked Questions

Is Wuxi Biologics Unsp/Adr publicly traded?

Yes, Wuxi Biologics Unsp/Adr is publicly traded.

What exchange does Wuxi Biologics Unsp/Adr trade on?

Wuxi Biologics Unsp/Adr trades on the OTC Traded

What is the ticker symbol for Wuxi Biologics Unsp/Adr?

The ticker symbol for Wuxi Biologics Unsp/Adr is WXXWY on the OTC Traded

What is the current price of Wuxi Biologics Unsp/Adr?

The current price of Wuxi Biologics Unsp/Adr is 10.55

When was Wuxi Biologics Unsp/Adr last traded?

The last trade of Wuxi Biologics Unsp/Adr was at 02/13/26 03:57 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Search Hotels in Sausalito

Find A Business

or Browse Listings

Wuxi Biologics Unsp/Adr (OP:WXXWY)

Price and Volume

Top News

Performance

More News

Frequently Asked Questions